Episode: 53 - Daphne Smyth on the Chinese Drug Development Market Expansion

With increasing efforts to scale into international markets, what can we expect from China's drug development industry? Joining the podcast is Daphne Smyth, head of global regulatory programs at Veristat, who shares her experience at this year's BioChina and what to expect for drug development on a global scale. Smyth explains why North America and Europe have been attractive market destinations for the Chinese market now more than ever, the regulatory reforms, and the potential bumps on the road getting Chinese drugs to foreign markets. Plus, host Deborah Borfitz gives you the latest news on the quantified financial value of risk-based quality management, a shingles vaccine for lowering dementia risk, a Parkinson's disease drug for treating depression, an AI for treating neuroblastoma, a link between hormonal birth control and brain health in older age, and Bayer's first strategic alliance with an academic medical center focused on clinical trials collaboration. 

Financial value of RBQM 

• Study in Therapeutic Innovation & Regulatory Science 
• News release from CluePoints 

Shingles vaccine may lower dementia risk 

• Study in Annals of Internal Medicine  
• News on the Brown University website  

Parkinson’s drug for treatment-resistant depression 

• Study in Nature Medicine  
• News on the Lund University website 

AI for improving neuroblastoma outcomes 

• Research article in APL Quantum  
• News on the University of Utah website 

Brain-protecting effect of hormone therapies 

• Study in NeuroImage 
• News on the University of Kansas website  

Bayer’s alliance with academic medical center 

• News on the University of Colorado Anschutz website 

Guest 

Daphne Smyth, head of global regulatory programs for Veristat  

• Article in Clinical Research News about opportunities in China 

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.